USFDA21 Aug 2026, 05:21 pm
Choksi Labs Receives 4 Observations from USFDA Inspection
AI Summary
Choksi Laboratories Ltd has announced that the United States Food & Drug Administration (USFDA) conducted an inspection of its central laboratory in Indore from August 17 to August 20, 2026. Following the inspection, the company received four observations. Choksi Laboratories is committed to addressing these observations comprehensively and will submit its response to the USFDA within the stipulated timeframe. The company reaffirms its dedication to complying with USFDA regulations and maintaining high standards of quality and regulatory compliance.
Key Highlights
- USFDA inspected Choksi Labs' central laboratory in Indore.
- Inspection took place between August 17-20, 2026.
- Company received 4 observations from USFDA.
- Choksi Labs will respond within the stipulated timeframe.
- Commitment to USFDA regulations and quality standards reaffirmed.
Price Impact
More from CHOKSILA